Cervical cancer is the abnormal growth of cancerous cells in the tissues
of the cervix. It is the world's fourth most common cause of death in women.
The disease can be classified as squamous cell carcinoma and adenocarcinoma.
Squamous cell carcinoma originates in the lining of the cervix, while
adenocarcinoma arises in cervical cells. Cervical cancer is caused due to the
infection of HPV. There are no signs and symptoms to identify the early stages
of cervical cancer, but it can be identified through regular check-ups. Vaginal
bleeding and pelvic pain are usually observed as signs and symptoms of cervical
cancer. Before cancer detected in the cervix, cervix cells go through changes,
called as dysplasia, in which abnormal cells start to expose in the cervical
tissue. Over a period, the abnormal cells may developed into cancer cells and
begin to grow and spread more deeply into the cervix and surrounding areas.
Technavio's analysts forecast the global cervical cancer market to grow
at a CAGR of 4.87% over the period 2014-2019.
Browse
Detail Report With TOC @ http://www.hexareports.com/report/global-cervical-cancer-market/details
Covered in this
Report
The report covers the current scenario and the growth prospects of the
global cervical cancer market for the period of 2015-2019. To calculate the
market size, the report considers revenue generated through the sales of
various drugs used in the treatment and prevention of cervical cancer.
Table Of Content
PART 01:
Executive summary
Highlights
PART 02: Scope
of the report
Market overview
Top-vendor offerings
Request
A Sample copy of This Report @ http://www.hexareports.com/sample/48252
PART 03: Market
research methodology
Research methodology
Economic indicators
PART 04:
Introduction
Key market highlights
PART 05: Disease
overview
Understanding the disease
Risk factors
Signs and symptoms
Screening
Diagnosis
Staging
Treatment
Epidemiology
PART 06: Market
landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Market
segmentation by application
Global prophylactic vaccines
market
Global therapeutic drugs market
PART 08: Market
segmentation by type of therapy
Global cervical cancer
therapeutics market by type of therapy
Chemotherapy
Targeted therapy
HPV vaccines
PART 09:
Geographical segmentation
PART 10: Key
brand analysis
PART 11:
Pipeline portfolio
PART 12: Market
drivers
PART 13: Impact
of drivers
PART 14: Market
challenges
PART 15: Impact
of drivers and challenges
Browse
Full Report @ http://www.hexareports.com/report/global-cervical-cancer-market/details
About
Us:
Hexa Reports is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact
Information:
Ryan
Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone
Number
1-800-489-3075
Email
Us: sales@hexareports.com
Our
Website: http://www.hexareports.com/
Our
Blog: http://deepresearch2015.blogspot.in/
No comments:
Post a Comment